Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells.

[1]  M. Cooper,et al.  The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis , 2016, Diabetologia.

[2]  G. Seki,et al.  Selective Insulin Resistance in the Kidney , 2016, BioMed research international.

[3]  H. Ren,et al.  Inhibition of D4 Dopamine Receptors on Insulin Receptor Expression and Effect in Renal Proximal Tubule Cells , 2016, Journal of the American Heart Association.

[4]  H. Kume,et al.  Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy. , 2015, Biochemical and biophysical research communications.

[5]  C. Bergamaschi,et al.  Crosstalk between the renal sympathetic nerve and intrarenal angiotensin II modulates proximal tubular sodium reabsorption , 2015, Experimental physiology.

[6]  W. Luo,et al.  Renal Denervation Attenuates Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice Independent of Blood Pressure Lowering , 2015, Hypertension.

[7]  Philip G Cox,et al.  Predicting bite force and cranial biomechanics in the largest fossil rodent using finite element analysis , 2015, Journal of anatomy.

[8]  H. Ren,et al.  Activation of D4 Dopamine Receptor Decreases Angiotensin II Type 1 Receptor Expression in Rat Renal Proximal Tubule Cells , 2015, Hypertension.

[9]  R. Carey,et al.  AT2 Receptor Activation Induces Natriuresis and Lowers Blood Pressure , 2014, Circulation research.

[10]  W. Chan,et al.  Angiotensin II type 2 receptor regulates the development of pancreatic endocrine cells in mouse embryos , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.

[11]  Lijun Li,et al.  Deletion of the insulin receptor in the proximal tubule promotes hyperglycemia. , 2013, Journal of the American Society of Nephrology : JASN.

[12]  R. Coward,et al.  The insulin receptor and the kidney , 2013, Current opinion in nephrology and hypertension.

[13]  M. Brands,et al.  Sodium-retaining effect of insulin in diabetes. , 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  H. Ren,et al.  Angiotensin II AT2 receptor decreases AT1 receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar–Kyoto rats , 2012, Journal of hypertension.

[15]  S. Najjar,et al.  Ouabain and Insulin Induce Sodium Pump Endocytosis in Renal Epithelium , 2012, Hypertension.

[16]  J. Sowers,et al.  Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. , 2012, American journal of physiology. Endocrinology and metabolism.

[17]  Zhenqi Liu,et al.  Angiotensin II Receptors Modulate Muscle Microvascular and Metabolic Responses to Insulin In Vivo , 2011, Diabetes.

[18]  C. Kahn,et al.  PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. , 2011, The Journal of clinical investigation.

[19]  H. Son,et al.  Angiotensin II Inhibits Insulin Binding to Endothelial Cells , 2011, Diabetes & metabolism journal.

[20]  T. Gilbertson,et al.  Insulin activates epithelial sodium channel (ENaC) via phosphoinositide 3-kinase in mammalian taste receptor cells. , 2011, American journal of physiology. Cell physiology.

[21]  V. A. Villar,et al.  Insulin increases D5 dopamine receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats. , 2009, American journal of hypertension.

[22]  Antony Vinh,et al.  AT2 receptors: Functional relevance in cardiovascular disease , 2008, Pharmacology & Therapeutics.

[23]  C. Kahn,et al.  Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor , 2008, Proceedings of the National Academy of Sciences.

[24]  E. Schleicher,et al.  Phosphorylation of Ser357 of Rat Insulin Receptor Substrate-1 Mediates Adverse Effects of Protein Kinase C-δ on Insulin Action in Skeletal Muscle Cells* , 2008, Journal of Biological Chemistry.

[25]  C. Ecelbarger,et al.  Blood pressure and sodium transporter and channel regulation in mice with targeted knockout of the insulin receptor from collecting duct principal cells , 2008 .

[26]  G. Shulman,et al.  Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease , 2007 .

[27]  Martin Paul,et al.  Physiology of local renin-angiotensin systems. , 2006, Physiological reviews.

[28]  R. Felder,et al.  D3 Dopamine Receptor Directly Interacts With D1 Dopamine Receptor in Immortalized Renal Proximal Tubule Cells , 2006, Hypertension.

[29]  H. Tohgi,et al.  Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets , 2005, Thrombosis and Haemostasis.

[30]  D. Sibley,et al.  Interaction of Angiotensin II Type 1 and D5 Dopamine Receptors in Renal Proximal Tubule Cells , 2005, Hypertension.

[31]  L. Navar,et al.  The intrarenal renin-angiotensin system in hypertension. , 2004, Kidney international.

[32]  L. Sechi,et al.  Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. , 2003, Kidney international.

[33]  R. Carey,et al.  Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. , 2003, Endocrine reviews.

[34]  Jian-Mei Li,et al.  Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. , 2002, Molecular endocrinology.

[35]  L. Daviet,et al.  Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell. , 2001, Cardiovascular research.

[36]  A. Strosberg,et al.  Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor. , 2000, Molecular endocrinology.

[37]  H. Matsubara,et al.  Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. , 1998, Circulation research.

[38]  S. Rabkin.  The angiotensin II subtype 2 (AT2) receptor is linked to protein kinase C but not cAMP-dependent pathways in the cardiomyocyte. , 1996, Canadian journal of physiology and pharmacology.

[39]  M. Baum.  Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. , 1987, The Journal of clinical investigation.

[40]  H. Ren,et al.  Activation of D 4 Dopamine Receptor Decreases Angiotensin II Type 1 Receptor Expression in Rat Renal Proximal Tubule Cells , 2016 .

[41]  C. Wilcox,et al.  Oxidative stress in hypertension: role of the kidney. , 2014, Antioxidants & redox signaling.

[42]  R. Carey,et al.  AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function , 2012, Pflügers Archiv: European Journal of Physiology.

[43]  G. Shulman,et al.  Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. , 2007, The Journal of clinical investigation.